Enhanced polo-like kinase 1 expression in myelodysplastic syndromes

BACKGROUND: Cancer is characterized by uncontrolled cellular proliferation, and Polo-like kinase 1 (PLK1), a key regulator of the cell cycle, is overexpressed in many cancers, including acute leukemia and lymphoma. However, the dynamics of PLK1 transcription in myelodysplastic syndromes (MDS) are un...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Kyoung Il, Park, Silvia, Shin, Seung-Hwan, Kwon, Yong-Rim, Kim, Hye-Joung, Kim, Yoo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614105/
https://www.ncbi.nlm.nih.gov/pubmed/31309087
http://dx.doi.org/10.5045/br.2019.54.2.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614105/
https://www.ncbi.nlm.nih.gov/pubmed/31309087
http://dx.doi.org/10.5045/br.2019.54.2.102

Ejemplares similares